[Perspectives opened up by the physiopathological understanding of psychiatric disorders].

Summarise with VIRAT
Authors: Nathalie Girault, Laura Quiroga, Stanislas Jedrecy, Simon Bertin, Ndyliam Djonouma, Philippe Fossati
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neuroimaging techniques have a rightful place in the field of psychiatry. They are essential for differential diagnosis, especially when the psychiatric presentation is atypical. Furthermore, they associate brain dysfunction with psychiatric disorders, but they cannot yet provide a definitive psychiatric diagnosis. However, from a therapeutic perspective, brain MRI is a very useful tool for neuronavigation techniques in combination with rTMS. From a neurobiological perspective, advances in genetics are allowing the development of genomic tests to guide antidepressant therapy and predict a diagnosis of bipolar disorder. In addition, psychedelics such as psilocybin offer promising alternatives for the treatment of depression. Similarly, ketamine, an antagonist of NMDA-type glutamatergic receptors, has shown efficacy in the management of suicidal crises and in the treatment of depressive disorders. Finally, antagonism of orexin receptors offer a new avenue for treating insomnia.

Fields of Study & Subjects

Treatment of Major Depression Mental Health and Psychiatry Deep Brain Stimulation and Movement Disorders

Publication details

Journal / source
PubMed
Volume
76
Issue
3
Pages
318–324
Publication date
1 March 2026
Language
FR